By activating CAR T cells only in the presence of an antibody switch, Travis Young and his team hope to make this cancer treatment safer and more effective.
Drug Discovery News
Switching on safer CAR T cell therapy
Stephanie is a science journalist and editor based in Los Angeles. She is the Managing Editor at The Scientist.
Stephanie DeMarco -- Science Writer 